Cargando…
Corrigendum: Real-world treatment patterns and outcomes among individuals receiving first-line pembrolizumab therapy for recurrent/metastatic head and neck squamous cell carcinoma
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390299/ https://www.ncbi.nlm.nih.gov/pubmed/37529689 http://dx.doi.org/10.3389/fonc.2023.1240947 |
| _version_ | 1785082449854726144 |
|---|---|
| author | Black, Christopher M. Hanna, Glenn J. Wang, Liya Ramakrishnan, Karthik Goto, Daisuke Turzhitsky, Vladimir Hair, Gleicy M. |
| author_facet | Black, Christopher M. Hanna, Glenn J. Wang, Liya Ramakrishnan, Karthik Goto, Daisuke Turzhitsky, Vladimir Hair, Gleicy M. |
| author_sort | Black, Christopher M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10390299 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103902992023-08-01 Corrigendum: Real-world treatment patterns and outcomes among individuals receiving first-line pembrolizumab therapy for recurrent/metastatic head and neck squamous cell carcinoma Black, Christopher M. Hanna, Glenn J. Wang, Liya Ramakrishnan, Karthik Goto, Daisuke Turzhitsky, Vladimir Hair, Gleicy M. Front Oncol Oncology Frontiers Media S.A. 2023-07-17 /pmc/articles/PMC10390299/ /pubmed/37529689 http://dx.doi.org/10.3389/fonc.2023.1240947 Text en Copyright © 2023 Black, Hanna, Wang, Ramakrishnan, Goto, Turzhitsky and Hair https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Oncology Black, Christopher M. Hanna, Glenn J. Wang, Liya Ramakrishnan, Karthik Goto, Daisuke Turzhitsky, Vladimir Hair, Gleicy M. Corrigendum: Real-world treatment patterns and outcomes among individuals receiving first-line pembrolizumab therapy for recurrent/metastatic head and neck squamous cell carcinoma |
| title | Corrigendum: Real-world treatment patterns and outcomes among individuals receiving first-line pembrolizumab therapy for recurrent/metastatic head and neck squamous cell carcinoma |
| title_full | Corrigendum: Real-world treatment patterns and outcomes among individuals receiving first-line pembrolizumab therapy for recurrent/metastatic head and neck squamous cell carcinoma |
| title_fullStr | Corrigendum: Real-world treatment patterns and outcomes among individuals receiving first-line pembrolizumab therapy for recurrent/metastatic head and neck squamous cell carcinoma |
| title_full_unstemmed | Corrigendum: Real-world treatment patterns and outcomes among individuals receiving first-line pembrolizumab therapy for recurrent/metastatic head and neck squamous cell carcinoma |
| title_short | Corrigendum: Real-world treatment patterns and outcomes among individuals receiving first-line pembrolizumab therapy for recurrent/metastatic head and neck squamous cell carcinoma |
| title_sort | corrigendum: real-world treatment patterns and outcomes among individuals receiving first-line pembrolizumab therapy for recurrent/metastatic head and neck squamous cell carcinoma |
| topic | Oncology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390299/ https://www.ncbi.nlm.nih.gov/pubmed/37529689 http://dx.doi.org/10.3389/fonc.2023.1240947 |
| work_keys_str_mv | AT blackchristopherm corrigendumrealworldtreatmentpatternsandoutcomesamongindividualsreceivingfirstlinepembrolizumabtherapyforrecurrentmetastaticheadandnecksquamouscellcarcinoma AT hannaglennj corrigendumrealworldtreatmentpatternsandoutcomesamongindividualsreceivingfirstlinepembrolizumabtherapyforrecurrentmetastaticheadandnecksquamouscellcarcinoma AT wangliya corrigendumrealworldtreatmentpatternsandoutcomesamongindividualsreceivingfirstlinepembrolizumabtherapyforrecurrentmetastaticheadandnecksquamouscellcarcinoma AT ramakrishnankarthik corrigendumrealworldtreatmentpatternsandoutcomesamongindividualsreceivingfirstlinepembrolizumabtherapyforrecurrentmetastaticheadandnecksquamouscellcarcinoma AT gotodaisuke corrigendumrealworldtreatmentpatternsandoutcomesamongindividualsreceivingfirstlinepembrolizumabtherapyforrecurrentmetastaticheadandnecksquamouscellcarcinoma AT turzhitskyvladimir corrigendumrealworldtreatmentpatternsandoutcomesamongindividualsreceivingfirstlinepembrolizumabtherapyforrecurrentmetastaticheadandnecksquamouscellcarcinoma AT hairgleicym corrigendumrealworldtreatmentpatternsandoutcomesamongindividualsreceivingfirstlinepembrolizumabtherapyforrecurrentmetastaticheadandnecksquamouscellcarcinoma |